Sign in
HI

HANOVER INSURANCE GROUP, INC. (THG)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 2025 delivered record operating EPS of $4.35 and GAAP diluted EPS of $4.30, with revenue of $1.654B; both EPS and revenue materially exceeded S&P Global consensus (EPS beat by ~$1.24; revenue beat by ~$45M)* .
  • Underwriting performance strengthened: combined ratio improved to 92.5% (ex-CAT 85.5%), with current accident year loss ratio ex-CAT down 2.8 pts YoY to 56.1% .
  • Segment trends: Specialty posted an 86.5% combined ratio and 4.6% NPW growth; Personal Lines rebounded with a 95.5% combined ratio and 3.7% NPW growth; Core Commercial grew NPW 4.4% with a 93.0% combined ratio .
  • Catalysts cited by management include enhanced catastrophe protection (cat bond upsized to $200M; tower to $2.05B exhaustion), expected 6–7% H2 net written premium growth, and accelerating AI-driven operating efficiency .

What Went Well and What Went Wrong

What Went Well

  • “Operating ROE of 18.7% and operating earnings of $4.35 per diluted share, both second quarter records,” underscoring disciplined underwriting and broad execution (CEO) .
  • Specialty achieved a mid-80s combined ratio (86.5%) with favorable prior-year development (3.5 pts), and strong property results in Marine and HSI .
  • Personal Lines margin recapture continued: current accident year combined ratio ex-CAT improved to 84.8% (−5.4 pts YoY), aided by earned pricing and lower frequency; homeowners pricing increased to 15.7% (CFO) .

What Went Wrong

  • Core Commercial loss ratio ex-CAT rose 80 bps YoY (to 56.5%), reflecting prudent increases in commercial auto picks amid rising severity/litigation (CFO) .
  • Catastrophe pressure persisted from SCS storms; Q2 CAT losses of ~$107.5M (7.0 pts) still meaningful despite improvement vs prior year .
  • Competitive pressure observed in certain middle-market property areas; management passed on underpriced business to protect thresholds (CEO/COO) .

Financial Results

MetricQ2 2024Q4 2024Q1 2025Q2 2025
Revenue ($USD Millions)$1,536.7 $1,584.3 $1,603.2 $1,654.4
Operating EPS ($USD)$1.88 $5.32 $3.87 $4.35
GAAP Diluted EPS ($USD)$1.12 $4.59 $3.50 $4.30
Combined Ratio (%)99.2% 89.2% 94.1% 92.5%
Combined Ratio ex-CAT (%)88.5% 87.5% 87.8% 85.5%
Net Investment Income ($MM)$90.4 $100.7 $106.1 $105.5

Segment performance

Segment MetricQ2 2024Q1 2025Q2 2025
Core Commercial NPW ($MM)$513.4 $604.6 $536.0
Core Commercial Combined Ratio (%)91.8% 103.4% 93.0%
Specialty NPW ($MM)$352.1 $358.3 $368.2
Specialty Combined Ratio (%)93.1% 87.7% 86.5%
Personal Lines NPW ($MM)$655.6 $547.9 $679.6
Personal Lines Combined Ratio (%)109.1% 89.7% 95.5%

Key KPIs

KPIQ2 2024Q1 2025Q2 2025
Renewal Price Increase – Core11.7% 11.1% 10.7%
Renewal Price Increase – Specialty11.7% 8.4% 7.8%
Renewal Price Increase – Personal18.5% 13.1% 12.3%
CAT Losses ($MM)$177.1 $107.6 $107.5
Current Accident Year Loss & LAE ex-CAT (Total)58.9% 58.3% 56.1%
Book Value per Share ($)$70.96 $84.56 $89.62
NPW Growth (Total)5.1% 3.9% 4.1%

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Catastrophe load (as % for Q3)Q3 2025n/a6.8% (CFO) New
Net Written Premium growthH2 2025n/a6–7% expected (CFO) New
Commercial Auto pricingGo-forwardDouble-digit soughtDouble-digit targeted (CFO) Maintained/Elevated
Specialty long-term CAY loss ratio targetLong-termLow-50s targetExpect results in line with low-50s (CFO) Maintained
Personal Lines PIFQ4 2025n/aReturn to positive PIF expansion (CFO) New
Cat occurrence reinsurance tower2025 programPrior limit lowerTower exhausts at $2.05B; retention $200M (CFO) Raised
Cat bond2025 programSmallerThird/largest cat bond upsized to $200M (CFO) Raised
Reinsurance cost2025 renewalsn/aDouble-digit reduction in risk-adjusted cost (loss-free program) (CFO) Improved

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 2024, Q1 2025)Current Period (Q2 2025)Trend
AI/technology initiatives“Continued investment in tools and technology” (Q4) ; Specialty growth supported by talent/technology (Q1) Generative AI for submission ingestion, triage, workflow automation; aim to double throughput in E&S; enterprise alignment (CEO/COO) Accelerating investment and deployment
Tariffs/macroTariffs noted in risk disclosures (Q1) Monitoring auto property severity for tariff impacts; modest back-half loss cost risk (CEO/CFO) Vigilant stance; limited impact so far
Personal Lines performanceStrong margin recovery in Q4; pricing gains (Q4) Ex-CAT CAY combined ratio 84.8%; Home pricing 15.7%; Umbrella disciplined (+23% price) (CFO) Improving margins; sustained pricing discipline
Reinsurance/CAT managementLower CAT incidence Q4; capital strength (Q4) Upsized cat bond, added $100M layer; tower to $2.05B; Q3 CAT load 6.8% (CFO) Strengthened catastrophe protection; better cost
Distribution/agent strategyn/aDifferentiation via select distribution and account focus; agent consolidation as opportunity (CEO) Reinforced go-to-market advantage
Middle market property competitivenessn/aElevated competition; selective pass on underpriced opportunities (CEO/COO) Discipline maintained; focus on target sectors

Management Commentary

  • “With an operating ROE of 18.7% and operating earnings of $4.35 per diluted share, both second quarter records, we’re delivering excellent performance across all businesses.” — John C. Roche, CEO .
  • “We achieved one of our best underwriting performances ever, with a combined ratio of 92.5%, and 85.5%, excluding catastrophes… reserves remain strong, supported by a disciplined methodology with favorable development in each segment.” — Jeffrey M. Farber, CFO .
  • “We are leveraging generative AI to automate submission ingestion, build triage functionality, and streamline workflow automation… intended to double throughput on high-quality submissions in E&S.” — CEO .
  • “We completed a successful renewal… upsized our catastrophe bond to $200 million… the cat occurrence program now exhausts at $2.05 billion with a $200 million retention.” — CFO .

Q&A Highlights

  • Specialty pricing resilience and mix: Management emphasized resilience aligned to loss trends, differentiation in lower-mid/small accounts, and growth in E&S (+22%), surety (+13%), healthcare (+8%) (CEO/President Specialty) .
  • Commercial auto reserving: CFO noted prudent increases in current-year and prior-year IBNR picks amid severity/litigation; line remains relatively small (~$400M premium) .
  • CAT load outlook: Q3 CAT load guided to 6.8%; improvements attributed to personal lines deductibles and thinning of large commercial PMLs (CFO) .
  • Investment income trajectory: Reinvestment rates around low-5% with continued pickup versus maturities; strong cash flows underpin continued NII strength (CFO) .
  • Distribution/geography: Comfortable footprint; diversifying within existing states; adding agents in targeted territories; strong account writer positioning (CEO/COO) .

Estimates Context

MetricQ2 2025 Consensus*Q2 2025 ActualQ1 2025 Consensus*Q1 2025 Actual
Primary EPS ($)3.10571*4.35 3.51429*3.87
Revenue ($MM)1,609.2*1,654.4 1,549.4*1,603.2
# EPS Estimates7*—7*—
# Revenue Estimates2*—3*—

Values retrieved from S&P Global.*

Implications: Material beats on both EPS and revenue suggest upward pressure on near-term estimates and potential positive revision momentum. Thin revenue coverage (2–3 estimates) implies higher dispersion risk but highlights surprise magnitude.

Key Takeaways for Investors

  • Underwriting momentum broad-based; ex-CAT combined ratio fell to 85.5% and CAY loss ratio ex-CAT to 56.1% — signaling sustained margin strength into H2 .
  • Specialty remains the earnings engine with favorable reserve development and disciplined property exposure; expect long-term CAY loss ratio near low-50s (CFO) .
  • Personal Lines margin recapture on track; homeowners pricing strength and lower frequency underpin improved ratios; management expects positive PIF in Q4 .
  • Reinsurance program materially fortified (cat bond $200M; tower $2.05B) with risk‑adjusted cost down double digits — reducing tail risk and earnings volatility (CFO) .
  • Commercial auto remains a watch-item: prudent reserving amid severity/litigation; pricing actions aim for double-digit increases (CFO) .
  • Investment income tailwind persists as reinvestment rates in low-5% range exceed roll-off yields; supports ROE durability (CFO) .
  • Near-term trading: EPS/revenue beats and stronger CAT protection are positive catalysts; medium-term thesis centers on specialty profitability, personal lines normalization, and tech/AI-enabled operating leverage .